Heartflow (NASDAQ:HTFL) Insider Campbell Rogers Sells 24,188 Shares of Stock

Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) insider Campbell Rogers sold 24,188 shares of the business’s stock in a transaction that occurred on Tuesday, November 17th. The stock was sold at an average price of $46.39, for a total transaction of $1,122,081.32. Following the completion of the transaction, the insider owned 64,424 shares of the company’s stock, valued at approximately $2,988,629.36. The trade was a 27.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Campbell Rogers also recently made the following trade(s):

  • On Thursday, October 22nd, Campbell Rogers sold 12,157 shares of Heartflow stock. The shares were sold at an average price of $55.01, for a total value of $668,756.57.
  • On Friday, September 18th, Campbell Rogers sold 12,156 shares of Heartflow stock. The shares were sold at an average price of $50.15, for a total value of $609,623.40.
  • On Tuesday, November 17th, Campbell Rogers sold 12,157 shares of Heartflow stock. The stock was sold at an average price of $46.39, for a total value of $563,963.23.
  • On Thursday, October 22nd, Campbell Rogers sold 23,933 shares of Heartflow stock. The stock was sold at an average price of $55.01, for a total value of $1,316,554.33.
  • On Friday, September 18th, Campbell Rogers sold 19,682 shares of Heartflow stock. The stock was sold at an average price of $50.15, for a total value of $987,052.30.

Heartflow Stock Performance

Shares of NASDAQ:HTFL traded down $1.26 during midday trading on Thursday, reaching $44.63. 1,279,655 shares of the company’s stock traded hands, compared to its average volume of 1,615,683. Heartflow, Inc. has a one year low of $20.13 and a one year high of $60.65. The company has a market cap of $3.92 billion, a price-to-earnings ratio of -48.51 and a beta of 2.50. The stock has a 50 day moving average of $51.84 and a 200 day moving average of $35.47.

Heartflow (NASDAQ:HTFL – Get Free Report) last released its quarterly earnings data on Thursday, November 12th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.18) by $0.15. Heartflow had a negative return on equity of 20.53% and a negative net margin of 33.11%. The company had revenue of $72.86 million during the quarter. During the same quarter in the previous year, the business posted ($0.27) earnings per share. Sell-side analysts predict that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HTFL has been the topic of a number of recent analyst reports. Morgan Stanley raised their price target on shares of Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a report on Friday, August 14th. Robert W. Baird boosted their price objective on shares of Heartflow from $56.00 to $68.00 and gave the company an “outperform” rating in a report on Friday, November 13th. UBS Group initiated coverage on shares of Heartflow in a report on Wednesday, September 9th. They set a “neutral” rating and a $55.00 price objective for the company. Piper Sandler restated an “overweight” rating and set a $64.00 price objective (up from $45.00) on shares of Heartflow in a research report on Tuesday, October 20th. Finally, Canaccord Genuity Group raised their target price on shares of Heartflow from $56.00 to $69.00 and gave the stock a “buy” rating in a report on Friday, November 13th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Heartflow presently has an average rating of “Moderate Buy” and an average target price of $60.12.

Get Our Latest Stock Report on Heartflow

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Algert Global LLC bought a new stake in shares of Heartflow during the 3rd quarter valued at about $2,960,000. Castleark Management LLC bought a new position in shares of Heartflow in the 3rd quarter worth approximately $4,713,000. Virtu Financial LLC bought a new position in shares of Heartflow in the 3rd quarter worth approximately $1,028,000. Allworth Financial LP boosted its holdings in shares of Heartflow by 56.5% in the third quarter. Allworth Financial LP now owns 828 shares of the company’s stock worth $41,000 after buying an additional 299 shares during the last quarter. Finally, Entropy Technologies LP boosted its holdings in shares of Heartflow by 7.1% in the third quarter. Entropy Technologies LP now owns 10,156 shares of the company’s stock worth $505,000 after buying an additional 672 shares during the last quarter.

About Heartflow

(Get Free Report)

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.

Featured Articles

Insider Buying and Selling by Quarter for Heartflow (NASDAQ:HTFL)

Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.